1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends

Analysis of Gilead Sciences

  • April 2016
  • 120 pages
  • Aruvian's R'search
Report ID: 242032

Summary

Table of Contents

Search Inside

Based in the United States, Gilead Sciences is a global leader in the marketing and development of anti-infective drugs. The company has approved products for the treatment of Hepatitis B & C, HIV/AIDS, fungal infections and influenza.

Aruvian Research presents Analysis of Gilead Sciences. A complete and comprehensive analysis of Gilead Sciences, includes an overview of the industry the company operates in, a PEST Framework Analysis of the industry, and then moves on to analyzing the company itself.

Company analysis from Aruvian includes a history of Gilead Sciences, a business segment analysis of the segments Gilead Sciences operates through, a look at the organization structure of the company, a geographical operating segments analysis, an analysis of the company’s major competitors.

A financial analysis of Gilead Sciences is presented in the report which includes a ratio analysis, basic profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Gilead Sciences completes this in-depth company analysis.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Market Access Impact (EU5) [HIV]

  • $ 5440
  • Industry report
  • April 2017
  • by Firstword Pharma

HIV drug market barriers: A help or a hindrance? Today’s tightly packed European HIV drug landscape is the culmination of numerous innovative developments over the last three decades. New market entrants ...

Market Access Impact (US) [HIV]

  • $ 5440
  • Industry report
  • April 2017
  • by Firstword Pharma

Are US market barriers helping or hindering your HIV brand? Today’s tightly packed US HIV drug landscape is the culmination of numerous innovative developments over the last three decades. New market ...

Global Antiviral Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • March 2017
  • by Infiniti Research Limited

About Antiviral Drugs Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.